Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Aug 28;13(1):14015.
doi: 10.1038/s41598-023-41112-6.

Prevalence of gastroparesis in diabetic patients: a systematic review and meta-analysis

Lianxin Li  1 , Luyao Wang  1 , Ruolan Long  1 , Linrui Song  1 , Rensong Yue  2
Affiliations
Meta-Analysis

Prevalence of gastroparesis in diabetic patients: a systematic review and meta-analysis

Lianxin Li et al. Sci Rep. .

Erratum in

Abstract

Although there was no significant heterogeneity in the meta-publication, sensitivity analyses revealed significant heterogeneity. Overall, the prevalence was higher in women (N = 6, R = 4.6%, 95% CI 3.1%, 6.0%, and I2 = 99.8%) than in men (N = 6, R = 3.4%, 95% CI 2.0%, 4.7%, and I2 = 99.6the %); prevalence of type 2 diabetes (N = 9, R = 12.5%, 95% CI 7.7%, 17.3%, and I2 = 95.4%) was higher than type 1 diabetes (N = 7, R = 8.3%, 95% CI 6.4%, 10.2%, and I2 = 93.6%); the prevalence of DGP was slightly lower in DM patients aged over 60 years (N = 6, R = 5.5%, 95% CI 3.3%, 7.7%, and I2 = 99.9%) compared to patients under 60 years of age (N = 12, R = 15.8%, 95% CI 11 15.8%, 95% CI 11.4%, 20.2%, and I2 = 88.3%). In conclusion, our findings indicate that the combined estimated prevalence of gastroparesis in diabetic patients is 9.3%. However, the sensitivity of the results is high, the robustness is low, and there are significant bias factors. The subgroup analysis revealed that the prevalence of DM-DGP is associated with factors such as gender, diabetes staging, age, and study method.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Literature screening process and results.
Figure 2
Figure 2
Total prevalence of DM-DGP patients.
Figure 3
Figure 3
Egger’s test.
Figure 4
Figure 4
Sensitivity analysis.
See this image and copyright information in PMC

References

    1. Magliano, D. & Boyko, E. J. IDF Diabetes Atlas. (International Diabetes Federation, 2021).
    1. Kuznetsov KO, Mikheeva AJ, Ishmukhametova AA, et al. Diabetic gastroenteropathy: Modern methods of diagnosis and treatment. Problem. Endokrinol. 2022;68(5):67–78. doi: 10.14341/probl13082. - DOI - PMC - PubMed
    1. Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: Gastroparesis. Am. J. Gastroenterol. 2022;117(8):1197–1220. doi: 10.14309/ajg.0000000000001874. - DOI - PMC - PubMed
    1. Camilleri M, Chedid V, Ford AC, et al. Gastroparesis. Nat. Rev. Dis. Primers. 2018;4(1):41. doi: 10.1038/s41572-018-0038-z. - DOI - PubMed
    1. Ye Y, Jiang B, Manne S, et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. 2021;70(4):644–653. doi: 10.1136/gutjnl-2020-321277. - DOI - PMC - PubMed

Publication types